A recent meta-analysis reveals no link between pathologic complete response and long-term survival in rectal cancer, challenging its use as a surrogate endpoint.

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...

Advances in instruments and tools, as well as focused collaborations, improve accuracy and extend the range of applications.

Reports record revenue of $20.4 million for the second quarter of 2025, an increase of $2.5 million, or 14%, compared to the ...

California and other liberal-led states sued the Trump administration Friday over efforts to end gender-affirming care ...

Parents of boys with Duchenne muscular dystrophy weigh in on drug innovation and medical regulation.

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

Leqvio can now be used alone, without addition of statin therapy, as adjunct to diet and exercise for LDL-C reduction in patients with hypercholesterolemia (high ...